Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis

British Journal of Cancer

Volumn 85, Issue 5, 2001, Pages 697-704

  Niketeghad, F ^a   Decker, H J ^b   Caselmann, W H ^c   Lund, P ^a   Geissler, F ^d   Dienes, H P ^a   Schirmacher, P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Comparative genomic hybridization; FISH; Hepatocarcinogenesis; Hepatocellular carcinoma; Oncogenes; Tumour suppressor genes

Indexed keywords

PROTEIN P53;

ARTICLE; CHROMOSOME 4Q; COMPARATIVE GENOMIC HYBRIDIZATION; DATA ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS DNA CELL DNA INTERACTION;

CARCINOMA, HEPATOCELLULAR; CHROMOSOME DELETION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LIVER NEOPLASMS; MALE; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035446479     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1963     Document Type: Article

References (54)

1. Genetic instability leads to loss of both p53 alleles in a human glioblastoma
2. A new retinoic acid receptor identified from a hepatocellular carcinoma
3. E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers
4. Global epidemiology of hepatocellular carcinoma
5. Selective G to T mutations of the p53 gene in hepatocellular carcinoma from southern Africa
6. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma
7. Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan
8. Somatic mutation of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
9. A physical map of 30,000 human genes
10. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors
11. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma
12. Quantitative analysis of comparative genomic hybridization
13. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors
14. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
15. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China
16. Molecular mechanisms of hepatocarcinogenesis
17. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
18. A locus for Fanconi anemia on 16q determined by homozygosity mapping
19. E-cadherin germline mutations in farmilial gastric cancer
20. TGF-beta signaling and cancer: Structural and functional consequences of mutations in Smads
21. Interphase cytogenetics: An approach to the detection of genetic aberrations in tumors
22. Mutation hotspot in the p53 gene in human hepatocellular carcinomas
23. Analysis of c-myc expression in a human hepatoma cell line
24. Genetic changes and histopathological grades in human hepatocellular carcinomas
25. Role of myc amplification and overexpression in cell growth, differentiation and death
26. Comparative genomic hybridization
27. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridisation
28. Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors
29. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinoma
30. Comprehensive allelotyping of hepatocellular carcinoma
31. Accumulation of allelic loss on arms of chromosome 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma
32. The role of insulin-like growth factor II in the malignant transformation of liver oval cells
33. Rearrangement of a common cellular DNA domain on chromosome 4 in human liver tumors
34. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth
35. Hepatocellular carcinoma
36. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region
37. Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis
38. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: Loss of E-cadherin expression in an undifferentiated carcinoma
39. Interaction of the Ski oncoproteth with Smad3 regulates TGF-beta signaling
40. Low incidence of BRCA2 mutations in breast carcinoma and other cancers
41. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma
42. Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin
43. Genetic manipulation of E-cadherin expression by epithelial tumour cells reveals an invasion suppressor role
44. Zytogenetik
45. Loss of somatic heterozygosity in hepatocetlular carcinoma
46. Ataxia teleangiectasia with hepatocellular carcinoma in a 15 year old girl and studies of her kindred
47. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analyses: Relationship to disease stage, tumor size, and cirrhosis
48. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
49. Identification of the breast cancer susceptibility gene BRCA2
50. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
51. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: Association with elevated α-fetoprotein
52. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma